Phcog.Net logo
Submit

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Pharmacognosy CommunicationsNOW IN
    Article

    Antibacterial Efficacy and Cytotoxicity of Terminalia avicennioides Guill. and Perr. Stem Bark Extract Against Resistant Pathogens

    Temiyefunolu A. Ngwu1, Oluwaseun. O Olasunkanmi1, Victor Akpe2, Ian Edwin Cock2★★ Corresponding author

    1. 1¹Department of Microbiology, Faculty of Science, Lagos State University, Lagos, NIGERIA. 2School of Environment and Science, Griffith University, Nathan Campus, Queensland, AUSTRALIA.

    CORRESPONDENCE

    Ian Edwin Cock

    i.cock@griffith.edu.au

    Received: 24-12-2025; Revised: 09-02-2026; Accepted: 16-04-2026.

    Volume 16, Issue 2 · pp. 85–94 · PUBLISHED 2026 · DOI: 10.5530/pc.2026.2.9

    View on Pharmacogn. Commn. original site ↗

    ABSTRACT

    Background: The global rise of antimicrobial resistance (AMR) has created an urgent need for alternative therapeutic agents, particularly from medicinal plants used in traditional medicine. Terminalia avicennioides Guill. and Perr. is widely used in West Africa for treating bacterial infections. Objectives: To evaluate the antibacterial efficacy and in vitro cytotoxicity of Terminalia avicennioides Guill. and Perr. stem bark extract. Materials and Methods: Stem bark was extracted using methanol-water (3:2, v/v; 60% methanol). Antibacterial activity was assessed using agar well diffusion assays, minimum inhibitory concentration (MIC), and minimum bactericidal concentration (MBC) tests against selected Gram-positive and Gram-negative bacteria. Cytotoxicity was evaluated using the brine shrimp lethality assay (BSLA). Results: The extract produced zones of inhibition ranging from 16-22 mm at test concentrations of 30-35 mg/mL. MIC values were as low as 0.05 mg/mL against Chromobacterium spp. and 0.25 mg/mL against Staphylococcus aureus, with similar MBC values. An LC₅₀ of 820 μg/mL was determined for the extract. Conclusion: These findings validate the traditional use of Terminalia avicennioides Guill. and Perr. for bacterial infections and highlight its potential as a source of novel antimicrobial agents. Despite moderate in vitro toxicity, further in vivo studies and dosage standardization are recommended before therapeutic application.

    KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Ngwu, T. A., Olasunkanmi, O. O., Akpe, V., & Cock, I. E. (2026). Antibacterial Efficacy and Cytotoxicity of Terminalia avicennioides Guill. and Perr. Stem Bark Extract Against Resistant Pathogens. Pharmacognosy Communications, 16(2), 85–94. https://doi.org/10.5530/pc.2026.2.9